These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 23720077)

  • 1. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
    Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
    J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary muscle involvement in myocardial infarction: initial results using multicontrast late-enhancement MRI.
    Yang Y; Connelly K; Graham JJ; Detsky J; Lee T; Walcarius R; Paul G; Wright GA; Dick AJ
    J Magn Reson Imaging; 2011 Jan; 33(1):211-6. PubMed ID: 21182141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
    Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
    J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicontrast late gadolinium enhancement imaging enables viability and wall motion assessment in a single acquisition with reduced scan times.
    Connelly KA; Detsky JS; Graham JJ; Paul G; Vijayaragavan R; Dick AJ; Wright GA
    J Magn Reson Imaging; 2009 Oct; 30(4):771-7. PubMed ID: 19787723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mass (>18g) of late gadolinium enhancement on CMR imaging is associated with major cardiac events on long-term outcome in patients with biopsy-proven extracardiac sarcoidosis.
    Agoston-Coldea L; Kouaho S; Sacre K; Dossier A; Escoubet B; Chillon S; Laissy JP; Rouzet F; Kutty S; Extramiana F; Leenhardt A; Borie R; Crestani B; Ou P
    Int J Cardiol; 2016 Nov; 222():950-956. PubMed ID: 27526366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
    Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
    Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis.
    Stanton KM; Ganigara M; Corte P; Celermajer DS; McGuire MA; Torzillo PJ; Corte TJ; Puranik R
    Heart Lung Circ; 2017 Nov; 26(11):1191-1199. PubMed ID: 28501519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
    Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
    Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.
    Matsumoto K; Ehara S; Sakaguchi M; Otsuka K; Hasegawa T; Shimada K; Yoshiyama M
    Osaka City Med J; 2015 Jun; 61(1):9-17. PubMed ID: 26434101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.
    Smedema JP; Snoep G; van Kroonenburgh MP; van Geuns RJ; Dassen WR; Gorgels AP; Crijns HJ
    J Am Coll Cardiol; 2005 May; 45(10):1683-90. PubMed ID: 15893188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy.
    Minutoli F; Di Bella G; Mazzeo A; Donato R; Russo M; Scribano E; Baldari S
    AJR Am J Roentgenol; 2013 Mar; 200(3):W256-65. PubMed ID: 23436870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.
    Renz DM; Röttgen R; Habedank D; Wagner M; Böttcher J; Pfeil A; Dietz R; Kivelitz D; Elgeti T
    Rofo; 2011 Sep; 183(9):834-41. PubMed ID: 21830182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of free-breathing late gadolinium-enhanced cardiovascular MRI for assessment of myocardial infarction: navigator-gated versus single-shot imaging.
    Matsumoto H; Matsuda T; Miyamoto K; Nakatsuma K; Sugahara M; Shimada T
    Int J Cardiol; 2013 Sep; 168(1):94-9. PubMed ID: 23040999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.
    Stevenson A; Bray JJH; Tregidgo L; Ahmad M; Sharma A; Ng A; Siddiqui A; Khalid AA; Hylton K; Ionescu A; Providencia R; Kirresh A
    JACC Cardiovasc Imaging; 2023 Mar; 16(3):345-357. PubMed ID: 36752432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
    Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
    ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.